Holen Sie sich die Stockscreener-App
12.38
4.12%
0.49
Handel nachbörslich:
12.24
-0.14
-1.13%
Schlusskurs vom Vortag:
$11.89
Offen:
$12
24-Stunden-Volumen:
2.45M
Relative Volume:
0.89
Marktkapitalisierung:
$1.42B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-6.1287
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
+5.72%
1M Leistung:
-5.71%
6M Leistung:
+54.17%
1J Leistung:
-21.35%
1-Tages-Spanne:
$11.99
$12.66
1-Wochen-Bereich:
$11.16
$12.66
52-Wochen-Spanne:
$6.78
$18.21
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
12.38 | 1.44B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
292.73 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
91.02 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.33 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.04 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.81 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
Institutional scanner results for 10x Genomics Inc.Share Buyback & Precise Trade Entry Recommendations - newser.com
SPT Labtech and 10x Genomics Partner to Automate Single Cell Workflows - SelectScience
10x Genomics (TXG) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
10X Genomics, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
Is 10x Genomics Inc. stock entering bullish territory2025 Market Sentiment & Growth Focused Investment Plans - newser.com
Is 10x Genomics Inc. stock supported by strong fundamentals2025 Macro Impact & Risk Adjusted Buy/Sell Alerts - newser.com
Can 10x Genomics Inc. stock deliver surprise earnings beatPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
Using flow based indicators on 10x Genomics Inc.July 2025 Short Interest & Weekly Stock Performance Updates - newser.com
Is 10x Genomics Inc. stock dividend yield sustainableTrade Risk Report & Expert Approved Momentum Trade Ideas - newser.com
How geopolitical tensions affect 10x Genomics Inc. stock2025 Technical Overview & Safe Capital Growth Tips - newser.com
SPT Labtech and 10X Genomics partner to automate single cell workflows - News-Medical
Advanced analytics toolkit walkthrough for 10x Genomics Inc.July 2025 Decliners & Momentum Based Trading Signals - newser.com
What’s the recovery path for long term holders of 10x Genomics Inc. - newser.com
Is 10x Genomics Inc. stock ready for a breakoutTrade Volume Report & Scalable Portfolio Growth Methods - newser.com
Single-cell Analysis Market to Reach USD 12.29 Billion by 2032, Driven by Expanding Oncology Research and Advanced Genomics – SNS Insider - GlobeNewswire Inc.
Is 10x Genomics Inc. (1KJ) stock bottoming after sell off2025 Trade Ideas & Real-Time Stock Price Movement Reports - newser.com
10X Genomics Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo
10x Genomics (NASDAQ:TXG) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025 - Eastern Progress
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know - Yahoo Finance
MarketsFinancial Advisors - FinancialContent
Trifecta Capital Advisors LLC Makes New $338,000 Investment in 10x Genomics $TXG - MarketBeat
How Investors May Respond To 10x Genomics (TXG) Patent Invalidation in Advanced Genomics Tools - Yahoo Finance
10x Genomics To Report Third Quarter 2025 Financial Results On November 6, 2025 - Barchart.com
Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - MSN
10X Genomics Hits Day Low of $11.54 Amid Price Pressure - Markets Mojo
10x Genomics (NASDAQ:TXG) Trading Down 7.6%What's Next? - MarketBeat
Why 10x Genomics Inc. (1KJ) stock stays on top picksWall Street Watch & Safe Capital Growth Tips - newser.com
How to use a screener to detect 10x Genomics Inc. breakoutsTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Public Employees Retirement System of Ohio Raises Position in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Upgraded to "Buy" at Wall Street Zen - MarketBeat
61,470 Shares in 10x Genomics $TXG Purchased by Lecap Asset Management Ltd. - MarketBeat
What analysts say about 10x Genomics Inc stockInstitutional Holding Changes & Small Investment Trading Plans - earlytimes.in
4 Best Genetic Sequencing Stocks To Buy in 2025 - The Motley Fool
Wealth Enhancement Advisory Services LLC Increases Stock Holdings in 10x Genomics $TXG - MarketBeat
10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Pattern recognition hints at 10x Genomics Inc. upside2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com
10x Genomics Aims For Growth Despite Funding Uncertainty - Finimize
Is 10x Genomics Inc. a candidate for recovery play2025 Macro Impact & Weekly Watchlist for Consistent Profits - newser.com
Why 10x Genomics Inc. (1KJ) stock is listed among top recommendationsExit Point & Intraday High Probability Setup Alerts - newser.com
10x Genomics Inc 1KJ Stock Analysis and ForecastFundamental Stock Analysis & Small Investment Growth Tips - earlytimes.in
What analysts say about 10x Genomics Inc 1KJ stockChart Pattern Recognition & Exceptional Capital Investment - Early Times
10x Genomics (TXG): Is the Market Overlooking the Company's True Value? - simplywall.st
78,249 Shares in 10x Genomics $TXG Purchased by Counterpoint Mutual Funds LLC - MarketBeat
10x Genomics $TXG Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Pallas Capital Advisors LLC Purchases 32,996 Shares of 10x Genomics $TXG - MarketBeat
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
10 X Genomics Inc-Aktie (TXG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer |
Aug 22 '25 |
Sale |
13.79 |
22,315 |
307,657 |
309,273 |
| Hindson Benjamin J. | See Remarks |
Aug 22 '25 |
Sale |
13.79 |
7,486 |
103,209 |
440,888 |
5.76%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):